A continued learning approach for model‐informed precision dosing: Updating models in clinical practice-Reference-Cited by-同舟云学术

A continued learning approach for model‐informed precision dosing: Updating models in clinical practice

Published:2021-12-27 Issue: Volume: Page:
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Maier Corinna¹²,Wiljes Jana¹,Hartung Niklas¹,Kloft Charlotte³,Huisinga Wilhelm¹

Affiliation:

1. Institute of Mathematics University of Potsdam Potsdam Germany

2. Graduate Research Training Program PharMetrX: Pharmacometrics & Computational Disease Modelling Freie Universität Berlin, Berlin and University of Potsdam Potsdam Germany

3. Department of Clinical Pharmacy and Biochemistry Institute of Pharmacy Freie Universität Berlin Berlin Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12745

Reference52 articles.

1. Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities

2. Precision Dosing: An Industry Perspective

3. Perspectives on Model‐Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations

4. Mixed Effects Models for the Population Approach

5. Precision dosing in clinical medicine: present and future

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy;Expert Opinion on Drug Metabolism & Toxicology;2024-08

2. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

3. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on drug response genes to predict prognosis and therapeutic response in ovarian cancer;Heliyon;2024-07

4. Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR;Clinical Pharmacology & Therapeutics;2024-04-24

5. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17